967285-000002 — Aavant Retatrutide
No SignalsAavant | Retatrutide, last activity 2 months ago
No community reports have been recorded for this batch.
A community group test of this batch has concluded. Aavant publishes certificates on fewer than a third of its batches; this one has none. First seen within the last month. No community reports have been recorded.
5 related batch concerns · 1 mention · summary from 1 source · updated Aug 15
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
No independent test result yet.
Related batches
5 of 5 tested
same lot series
1 community mention, no summary yet
same lot series
Tirzepatide, same vendor
1 community mention, no summary yet
APS
An independent test found endotoxin at 1,437.86 EU/vial, far exceeding the 10 EU/vial working limit, while the vendor's…
same lot series
Community Intelligence
- 1 concern report involving REPTN
- 2 concern reports involving 2026041210
- 4 concern reports involving XTP-R30-003
- 1 concern report involving JP20250821
- 1 concern report involving REPTN-1
Reported against other Aavant Retatrutide batches, not this one.
Also known as: 967285000002
Activity
Complete: Aavant (ACR) Reta 24MG -Green Caps batch # 967285-000002
Vendor
Aavant